666

LI KANG BIOMEDICAL CO LTD

No trades
See on Supercharts
Next report date
Report period
Q1 2024
EPS estimate
Revenue estimate
Market capitalization
‪1.58 B‬TWD
‪110.99 M‬TWD
‪629.38 M‬TWD
Beta (1Y)
0.17

About LI KANG BIOMEDICAL CO LTD

CEO
Yu Hsiu Cheng
Headquarters
Taipei
Founded
1985
ISIN
TW0006242001
FIGI
BBG000FSKC11
Li Kang Biomedical Co. Ltd. engages in the tourism businesses, telemarketing as well as the manufacturing and sales of cosmetics and hygienic drinks. The company sales supplement, cosmetics and hygienic drinks product. The company was founded on April 16, 1985 and is headquartered in Tainan, Taiwan.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 6242 is 51.7 TWD — it has increased by 0.58% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange LI KANG BIOMEDICAL CO LTD stocks are traded under the ticker 6242.
LI KANG BIOMEDICAL CO LTD is going to release the next earnings report on May 3, 2024. Keep track of upcoming events with our Earnings Calendar.
6242 stock is 0.97% volatile and has beta coefficient of 0.17. Check out the list of the most volatile stocks — is LI KANG BIOMEDICAL CO LTD there?
Yes, you can track LI KANG BIOMEDICAL CO LTD financials in yearly and quarterly reports right on TradingView.
6242 stock has risen by 0.58% compared to the previous week, the month change is a 4.26% fall, over the last year LI KANG BIOMEDICAL CO LTD has showed a 11.27% decrease.
6242 net income for the last quarter is ‪31.00 M‬ TWD, while the quarter before that showed ‪19.05 M‬ TWD of net income which accounts for 62.76% change. Track more LI KANG BIOMEDICAL CO LTD financial stats to get the full picture.
Today LI KANG BIOMEDICAL CO LTD has the market capitalization of ‪1.58 B‬, it has decreased by 1.37% over the last week.
Yes, 6242 dividends are paid annually. The last dividend per share was 2.00 TWD. As of today, Dividend Yield (TTM)% is 3.27%. Tracking LI KANG BIOMEDICAL CO LTD dividends might help you take more informed decisions.
LI KANG BIOMEDICAL CO LTD dividend yield was 4.29% in 2023, and payout ratio reached 60.38%. The year before the numbers were 3.55% and 41.59% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 6242 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LI KANG BIOMEDICAL CO LTD stock right from TradingView charts — choose your broker and connect to your account.
6242 reached its all-time high on Jul 26, 2007 with the price of 725.0 TWD, and its all-time low was 11.7 TWD and was reached on Feb 12, 2014.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So LI KANG BIOMEDICAL CO LTD technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating LI KANG BIOMEDICAL CO LTD stock shows the sell signal. See more of LI KANG BIOMEDICAL CO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. LI KANG BIOMEDICAL CO LTD EBITDA is ‪145.12 M‬ TWD, and current EBITDA margin is 23.03%. See more stats in LI KANG BIOMEDICAL CO LTD financial statements.